Who has invested in Exicure?

Bill Gates, AbbVie Ventures, Eric Lefkofsky are named among the investors backing Exicure.

Exicure Funding: $100M Raised, Series C (2016)

Exicure funding overview

Exicure is a Biotech company based in Chicago. Exicure has raised $100M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in August 2016. The round record for Exicure runs through 2016; nothing later has been disclosed. Investors on record include Bill Gates, AbbVie Ventures, Eric Lefkofsky. 3 distinct backers are named across the disclosed rounds.

Exicure at a glance

Total raised: $100M
Latest round: Series C
Latest round date: August 2016
Industry: Biotech
Headquarters: Chicago
Notable investors: Bill Gates, AbbVie Ventures, Eric Lefkofsky

Frequently asked about Exicure funding

How much has Exicure raised?: Exicure has raised $100M in total disclosed funding across the rounds on record.
Who has invested in Exicure?: Bill Gates, AbbVie Ventures, Eric Lefkofsky are named among the investors backing Exicure.
What was the latest Exicure funding round?: The most recent disclosed round is a Series C, announced in August 2016.
Where is Exicure based?: Exicure is based in Chicago.
What sector does Exicure operate in?: Exicure is tracked under Biotech from Chicago, with $100M in disclosed funding.
When did Exicure last raise?: The last disclosed Exicure round closed in August 2016 at Series C.

Round data for Exicure is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in Chicago and backer lists below.

Exicure Funding: $100M Raised, Series C (2016)

Exicure funding overview

Exicure at a glance

Frequently asked about Exicure funding

Companies related to Exicure (40)

Browse related funding lists (5)